Pages that link to "Q85554112"
Jump to navigation
Jump to search
The following pages link to PD-1-targeted immunotherapy: recent clinical findings (Q85554112):
Displaying 20 items.
- Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances (Q26827475) (← links)
- The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention (Q27024781) (← links)
- Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. (Q30235405) (← links)
- TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells (Q34080755) (← links)
- Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation (Q34364876) (← links)
- Specific increase in potency via structure-based design of a TCR. (Q34383054) (← links)
- Inclusion of CD80 in HSV targets the recombinant virus to PD-L1 on DCs and allows productive infection and robust immune responses (Q38309348) (← links)
- PD-L1 testing, fit for routine evaluation? From a pathologist's point of view (Q38774259) (← links)
- Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers. (Q39004582) (← links)
- Radiotherapy and immunotherapy: a beneficial liaison? (Q39017268) (← links)
- Elevated Foxp3/CD8 Ratio in Lung Adenocarcinoma Metastatic Lymph Nodes Resected by Transcervical Extended Mediastinal Lymphadenectomy (Q41430954) (← links)
- PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy (Q42325128) (← links)
- How to evaluate the immune status of lung cancer patients before immunotherapy (Q47167817) (← links)
- Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer (Q58698592) (← links)
- Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response. (Q64916418) (← links)
- ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression (Q88783218) (← links)
- Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and Challenges (Q90027962) (← links)
- CXCR4 inhibition modulates the tumor microenvironment and retards the growth of B16-OVA melanoma and Renca tumors (Q90121655) (← links)
- First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting (Q90494693) (← links)
- MicroRNA-519 inhibits hypoxia-induced tumorigenesis of pancreatic cancer by regulating immune checkpoint PD-L1 (Q92835342) (← links)